Evidence map›Paper›PMID 31482191›Full record

Observational studyNeuroradiology2019

Endovascular treatment of acute intracranial vertebrobasilar artery occlusion: a multicenter retrospective observational study.

Tao Quan, Haiman Hou, Wenjun Xue, Guangzhou Yu, Hengfei Ma, Jiachen Sun, Sheng Guan, Yuming Xu, Haowen Xu

Abstract readMulticenter StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in Neuroradiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 7 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 7 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Guideline
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Safety of Glycoprotein IIb-IIIa Inhibitors Used in Stroke-Related Treatment: A Systematic Review and Meta-Analysis.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Pooled it
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Tao QuanDepartment of Interventional Neuroradiology, The First Affiliated Hospital of Zhengzhou University, Road Jianshe No. 1, Zhengzhou City, 450052, China.
Haiman HouDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wenjun XueDepartment of Neurology, The First People's Hospital of Pingdingshan City, Pingdingshan, China.
Guangzhou YuDepartment of Neurology, The Centre Hospital of Zhumadian City, Zhumadian, China.
Hengfei MaDepartment of Neurology, The First People's Hospital of Pingdingshan City, Pingdingshan, China.
Jiachen SunDepartment of Interventional Neuroradiology, The First Affiliated Hospital of Zhengzhou University, Road Jianshe No. 1, Zhengzhou City, 450052, China.
Sheng GuanDepartment of Interventional Neuroradiology, The First Affiliated Hospital of Zhengzhou University, Road Jianshe No. 1, Zhengzhou City, 450052, China.
Yuming XuDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Haowen XuDepartment of Interventional Neuroradiology, The First Affiliated Hospital of Zhengzhou University, Road Jianshe No. 1, Zhengzhou City, 450052, China. neuron@126.com.ORCID http://orcid.org/0000-0003-0364-7064
First Affiliated Hospital of Zhengzhou University · CNPingdingshan University · CNZhumadian Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aimed to evaluate prognostic parameters associated with favorable clinical prognosis and assess the feasibility and safety of three different treatment strategies in patients with acute intracranial vertebrobasilar artery occlusion (VBAO).

methodsA total of 159 patients with acute VBAO at 3 stroke centers between September 2015 and October 2018 were retrospectively analyzed. Eighty-nine patients underwent mechanical thrombectomy (MT) alone, 43 underwent MT with additional rescue angioplasty, and 27 underwent primary balloon angioplasty (without or with stenting). In patients treated with primary or rescue balloon angioplasty (without or with stenting), a low-dose intra-arterial tirofiban injection was used. The reperfusion status was assessed after the procedure, and the functional outcome was assessed at 90-day follow-up. The baseline characteristics and 90-day prognosis of three different treatment subgroups were comparatively analyzed.

resultsOverall, successful reperfusion and a favorable outcome were achieved in 96.86% (154/159) and 46.54% (74/159) patients, respectively. The onset to puncture time (461.96 min vs 603.59 min, P = 0.000), procedure time (64.12 min vs 70.47 min, P = 0.007), and onset to reperfusion time (526.08 min vs 674.47 min, P = 0.000) were significantly shorter in patients with favorable outcomes than in those with poor outcomes. Among different endovascular treatment subgroups, no significant differences were found in successful reperfusion and 90-day outcome. Low-dose tirofiban did not increase the risk of symptomatic intracranial hemorrhage and the 90-day mortality in patients with acute VBAO.

conclusionIndividualized endovascular treatment strategy for selected patients with acute VBAO could achieve satisfactory reperfusion rate and favorable prognosis.

Indexed as

Endovascular ProceduresAgedAngioplastyCerebral AngiographyFemaleFibrinolytic AgentsHumansMaleMiddle AgedPrognosisRetrospective StudiesStentsThrombectomyTirofibanVertebrobasilar InsufficiencyFibrinolytic AgentsTirofibanAngioplastyMechanical thrombectomyPrognosisTirofibanVertebrobasilar artery occlusion

Identifiers

PMID31482191
OpenAlexW2972006647

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.